https://pubmed.ncbi.nlm.nih.gov/36822480/ Acute liver failure

J Hepatol. 2023 Feb 21;S0168-8278(23)00101-0.
doi: 10.1016/j.jhep.2023.02.013.Online ahead of print.

Outbreak of indeterminate acute liver failure in children with adenoviraemia - Not a new disease

Barath Jagadisan 1, Anita Verma 2, Maesha Deheragoda 3, Akash Deep 4, Tassos Grammatikopoulos 5, Malur Sudhanva 6, Sanjay Bansal 7, Nedim Hadzic 8, Sunitha Vimalesvaran 9, Nigel Heaton 10, Anil Dhawan 11

Abstract

https://pubmed.ncbi.nlm.nih.gov/36816379/ Cholangitis

Front Pediatr. 2023 Feb 3;11:1094895.
doi: 10.3389/fped.2023.1094895. eCollection 2023.

Neonatal sclerosing cholangitis with novel mutations in DCDC2 (doublecortin domain-containing protein 2) in Chinese children

Xia Wei 1, Yuan Fang 1, Jian-She Wang 2, Yi-Zhen Wang 1, Yuan Zhang 3, Kuerbanjiang Abuduxikuer 2, Lian Chen 4

Abstract

Background: Neonatal sclerosing cholangitis (NSC) is a rare and severe autosomal recessive inherited liver disease with mutations in DCDC2, commonly requiring liver transplantation (LT) for decompensated biliary cirrhosis in childhood.

https://pubmed.ncbi.nlm.nih.gov/36816376/ Metabolic liver disease

Front Pediatr. 2023 Feb 3;11:1084336.
doi: 10.3389/fped.2023.1084336. eCollection 2023.

Clinical features and enzyme replacement therapy in 10 children with Fabry disease

Qian Li 1 2, Jing Wang 1 2, Minle Tian 3, Zhenle Yang 1 2, Lichun Yu 1 2, Suwen Liu 1 2, Cong Wang 1 2, Xiaoyuan Wang 1 2, Shuzhen Sun 1 2

Abstract

Objective: To summarize the clinical features, diagnosis and enzyme replacement therapy(ERT) of Fabry disease (FD) in children.
Methods: The clinical data, laboratory tests, genetic variations and treatment of 10 FD children diagnosed in Shandong Provincial Hospital from September 2020 to June 2022 were retrospectively analyzed.